Publications by authors named "Sandra Zanger"

Claim this Profile
P
Pyridyl-Ala in the third position of radiolabeled somatostatin antagonists: the effect of regioisomeric substitution.
Rosalba Mansi, Natalie Bertarelli, Luigi Del Pozzo, Sandra Zanger, Tais Basaco Bernabeu

EJNMMI Radiopharm Chem· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cu-PSMA-Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging.
Tais Basaco Bernabeu, Rosalba Mansi, Luigi Del Pozzo, Sandra Zanger, Raghuvir H Gaonkar

J Nucl Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumors.
Joana Grand-Guillaume, Rosalba Mansi, Raghuvir H Gaonkar, Sandra Zanger, Melpomeni Fani

J Transl Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPECT Imaging of SST2-Expressing Tumors with Tc-Based Somatostatin Receptor Antagonists: The Role of Tetraamine, HYNIC, and Spacers.
Raghuvir Haridas Gaonkar, Fabius Wiesmann, Luigi Del Pozzo, Lisa McDougall, Sandra Zanger

Pharmaceuticals (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis